Correlation of serum magnesium and serum lipid levels in hemodialysis patients

Dialysis and Transplantation

Volumn 27, Issue 10, 1998, Pages 644-648

  Robles, Nicolas R ^a   Escola, Jose M ^a   Albarran, Luis ^b   Espada, Rosa ^b   Cruz, Angel ^c  

^a HOSPITAL INFANTA CRISTINA   (Spain)

^b Clinica Phermodiálisis   (Spain)

^c Hospital Provincial   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A; LIPID; MAGNESIUM; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; BLOOD ANALYSIS; BLOOD CHEMISTRY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CORRELATION FUNCTION; DYSLIPIDEMIA; FEMALE; HEMODIALYSIS; HUMAN; HUMAN CELL; LIPID BLOOD LEVEL; LIPID METABOLISM; MAGNESIUM BLOOD LEVEL; MALE; PRIORITY JOURNAL; REVIEW; STATISTICAL ANALYSIS; UREMIA;

EID: 0031656050     PISSN: 00902934     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Lidner A, Charra B, Sherrard D, Scribner BM. Accelerated atherosclerosis in prolonged maintenance hemodialysis N Engl J Med 1974; 290:697-701.
2. Ma KW, Greene EL, Raij L. Cardiovascular risk factors in chronic renal failure and hemodialysis populations. Am J Kidney Dis 1992; 19:505-513.
3. Pedro-Botet J, Senti M, Rubies-Prat J, Pelegri A, Romero R. When to treat dyslipidaemia of patients with chronic renal failure on haemodialysis? A need to define specific guidelines. Nephrol Dial Transpl 1996; 11:308-313.
4. Lacour B, Roullet JB, Beyne P, Kreis H, Thevenin M, Drueke T. Comparison of several atherogenicity indices by the analysis of serum lipoprotein composition in patients with chronic renal failure with or without haemodialysis, and in renal transplant recipients J Clin Chem Clin Biochem 1985; 23:805-810.
5. Coburn JR, Popovtzer MM, Massry SG, Kleeman CR. The physiochemical state and renal handling of divalent ions in chronic renal failure. Arch Intern Med 1969; 164:202-208
6. Bersohn I, Oelofse PJ. Correlation of serum-magnesium and serum-cholesterol levels in South African Bantu and European subjects. Lancet 1957; i:1020-1021.
7. Rayssiguier Y, Gueux E, Weiser D. Effects of magnesium deficiency on lipid metabolism in rats fed a high carbohydrate diet J Nutr 1981; 111:1877-1883.
8. Inagaki O, Shono T, Nakagawa K, Gomikawa S, Mori H, Fujita Y. Effects of magnesium deficiency on lipid metabolism in uremic rats. Nephron 1990; 55:176-180.
9. Auguet T, Senti M, Rubies-Prat J, Pelegri A, Pedro-Botet J, Nogues X, et al. Serum lipoprotein (a) concentration in patients with chronic renal failure receiving haemodialysis: Influence of apohpoprotein (a) genetic polymorphism. Nephrol Dial Transpl 1993; 8:1099-1103
10. Cheung AK, Wu LL, Kablitz C, Leypoldt JK. Atherogenic lipids and lipoproteins in hemodialysis patients. Am J Kidney Dis 1993; 22:271-276.
11. Rostand STG, Kirk KA, Rutsky EA. Relationship of coronary risk factors to hemodialysis-associated ischemic heart disease. Kidney Int 1982; 22:304-308
12. Degoulet P, Legrain M, Reach J, Aime F, Devries C, Rojas P, et al. Mortality risk factors in patients treated by chronic hemodialysis: Report of the Diaphane Collaborative Study. Nephron 1982; 31:103-110.
13. Study Group of the European Atherosclerosis Society. Strategies for the prevention of coronary heart disease: A policy statement of the European Atherosclerosis Society. Eur Heart J 1987; 8:77-88.
14. Vitale JJ, Velez H, Guzman C, et al. Magnesium deficiency in the cebus monkey. Circ Res 1963; 12:642-650.
15. Davis WH, Leary WP, Reyes AJ, Olhaberry JV. Monotherapy with magnesium increases abnormally low high-density lipoprotein cholesterol: A clinical assay. Curr Ther Res 1984; 36:341-347.
16. Bagdade JD, Yee E, Wilson DE, Shafrir E. Hyperlipidemia in renal failure: Studies of plasma lipoprotein, hepatic triglyceride production, and tissue lipoprotein lipase in a chronically uremic rat model. J Lab Clin Med 1978, 91:176-186.
17. Hernandez ML, Martinez MJ, Chico Y, Fernandez De Marticorena I, Lacort M, Ochoa B. Divalent metal ions as modulators of rat liver microsomal cholesterol esterase. Rev Esp Fisiol 1993, 49:107-114.
18. Martinez MJ, Hernandez ML, Lacort M, Ochoa B. Regulation of rat liver microsomal cholesterol ester hydrolase by reversible phosphorylation. Lipids 1994; 29:7-13.
19. Shoji T, Nishizawa Y, Nishitani H, Yamakawa M, Morii H. Impaired metabolism of high-density lipoprotein in uremic patients. Kidney Int 1992; 41 1651-1653.
20. Massry SG, Coburn JW, Kleeman CR. Evidence for suppression of parathyroid gland activity by hypermagnesemia. J Clin Invest 1970; 49:1619-1629
21. 3. treatment on lipid levels in uremic hemodialysis patients. Int J Artif Org 1992; 15:704-707.